Betapace (sotalol) is an antiarrhythmic medication used to treat abnormal heart rhythms, or arrhythmias. It is classified as a Class II antiarrhythmic, which means that it works by blocking certain electrical signals in the heart that can cause an irregular heartbeat. Betapace is used to treat a variety of arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia.
Betapace was first developed in the 1970s by the pharmaceutical company Bristol-Myers Squibb. It was approved by the U.S. Food and Drug Administration (FDA) in 1982 and is still widely used today. Betapace is available in both tablet and injectable form.
The active ingredients in Betapace are sotalol hydrochloride and potassium chloride. Sotalol hydrochloride is an antiarrhythmic medication that works by blocking certain electrical signals in the heart. Potassium chloride is a mineral that helps to regulate the electrical signals in the heart.
Betapace has a number of advantages over other antiarrhythmic medications. It is generally well-tolerated and has fewer side effects than other medications. It is also effective in treating a variety of arrhythmias and can be used in both tablet and injectable form.
Betapace is also known by its generic name, Sotalol, and other brand names such as Betapace AF and Sorine. It is available in both tablet and injectable form.
Betapace is an effective antiarrhythmic medication that has been used to treat a variety of arrhythmias since its approval by the FDA in 1982. It works by blocking certain electrical signals in the heart and is generally well-tolerated with fewer side effects than other medications. Its active ingredients are sotalol hydrochloride and potassium chloride, and it is available in both tablet and injectable form.